Aura Biosciences, Inc.
AURA
$5.36
-$0.04-0.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -22.77% | -3.47% | -3.20% | 10.96% | -19.55% |
| Total Depreciation and Amortization | -7.03% | 0.00% | 2.29% | -5.56% | -5.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.90% | -4.28% | 23.99% | -26.61% | 21.86% |
| Change in Net Operating Assets | -127.89% | 95.83% | 125.36% | -434.46% | 151.73% |
| Cash from Operations | -56.83% | 5.30% | 34.04% | -40.63% | -12.88% |
| Capital Expenditure | 12.32% | 35.05% | -496.59% | 72.24% | -252.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 193.20% | -49.77% | 114.74% | 110.56% | -513.48% |
| Cash from Investing | 200.28% | -50.16% | 111.16% | 110.43% | -516.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -24.16% | 762.65% | -67.19% | -99.73% | 5,618.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -24.16% | 762.65% | -67.19% | -99.73% | 5,618.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 234.66% | -222.97% | 125.64% | -1.93% | -284.95% |